Chr. Hansen A/s

Patrick Derkx

Mette Dines Cantor

Thomas Janzen

Beatrice Nielsen

Inge Helmer Knap

Eric Johansen

Thomas Dyrmann Leser

Ane Knarreborg

Jeorgos Trihaas

Birgitte Stuer-Lauridsen

Lund Bente

Kim Ib Soerensen

Gunnar Oeregaard

Tina Styrishave

Bente Lund

Vera Kuzina Poulsen

Karin Bjerre

Jonna Nielsen

Robert Lantz

The present invention is directed to a method of producing astrain comprising the steps of

Method of producing Streptococcus thermophilus mutant strains

A method for producing a lactic acid bacteria fermented milk product comprising fermenting milk with both inoculated lactic acid bacteria (LAB) and inoculatedbacteria.

Fermented milk inoculated with both lactic acid bacteria (LAB) and

The present invention is directed to a method of producing astrain comprising the steps of a) Providing a mother strain in the form ofDSM32502, b) Growing a culture of the mother strain in the presence of a bacteriophage, to which the mother strain is not resistant, to obtain a number of mutant strains, which are resistant to the said bacteriophage, c) Measuring the acidification time of the bacteriophage-resistant mutant strains and the mother strain in a milk base and selecting at least one mutant strain with a reduced acidification time as compared to the mother strain to obtain a fast-acidifying mutant strain.

Method of producingmutant strains

The present invention relates to a bacterial cell with texturizing property, starter cultures comprising the cell, and dairy products manufactured using the bacterial cell.

Bacteria

Novelsubsp.lactic acid bacterium strain having improved texturizing properties and method of using the strain for producing a food product.

EPS gene cluster of texturizing lactic acid bacteria

Astrain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol antimicrobial activity againstand; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species. Some of thewere further identified assubsp.whereas others were identified assubsp.. Astrain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.

Antibiotic sensitivestrains having antimicrobial effect againstandand having high sporulation capacity

Methods are provided for assaying whether acomposition comprising at least onestrain is capable of increasing the amount of sugar available from animal feed comprising non-starch polysaccharides (NSP) in vivo when thecomposition and animal feed are fed to an animal. Methods also are provided for increasing the amount of sugar available from animal feed comprising non-starch polysaccharides (NSP) when the animal feed is fed to an animal, comprising adding to the animal feed acomposition comprising at least onestrain, wherein the composition produces 120 hexose equivalents (&#x3bc;mol/ml) or more when measured by the method described herein. Animal feeds comprising 14% (w/w) or more of non-starch polysaccharides (NSP) if the animal feed is for a piglet, lactating sow, broiler or layer, or 19% (w/w) or more of non-starch polysaccharides (NSP) if the animal feed is for a grower-finisher pig or gestating sow, and acomposition comprising at least onestrain, as well as methods and uses relating thereto, also are provided.

[object Object]

Astrain characterized by (i): sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline and chloramphenicol; (ii) antimicrobial activity againstand; and (iii) a sporulation percentage of at least 80 when measured after 2 days of incubation. The invention further relates to a method for selecting such strains. Many of the identified strains according to the invention are of the species. Some of thewere further identified assubsp.whereas others were identified assubsp.. Astrain of the invention may be used as a feed additive to animal feed where it has a probiotic effect.

A bacillus composition characterized by fast germination and outgrowth in bile salts (simulated gut environment) and by producing a compound of interest. The bacillus composition may be used as supplement in animal feed where it has a probiotic (health promoting) effect and increases the digestion and availability of nutrients from animal feeds.

Acomposition characterized by fast germination and outgrowth in bile salts (simulated gut environment) and by high-level secretion of essential amino acid. Thecomposition may be used as supplement in animal feed where it has a probiotic (health promoting) effect and increases the digestion and availability of nutrients from animal feeds.

Growing community of inventors

Tikoeb, Denmark

Patrick Derkx